Sanggu Medical Robot Product Introduction

2020-03-24

After continuous R&D and innovation by the company, the seventh-generation intelligent drug compounding robot IDolphin7 for hazardous drug compounding has now been launched.

1. Features of the IDOLPHIN Intelligent Intravenous Drug Compounding Robot

• Sterile drug compounding environment

• Seamless integration of prescription information, prescription and drug verification

• Disposable dedicated sterile drug dissolver for drug compounding robots

• Advanced visual algorithm control and compounding quality control procedures

• Full support for clinical chemotherapy drug compounding, strong adaptability

• High compounding efficiency, safe and stable equipment operation

• Separated disposal of medical waste

2. Equipment Performance

• Fully automatic compounding: Replaces manual labor to fully automatically complete the intravenous drug compounding process in an enclosed, negative-pressure, Class 100 purified space, achieving complete isolation from medical staff during the drug compounding process. Medical waste can be classified and managed, and the robot can automatically identify the storage amount of medical waste in the internal trash bin; when full, it can be fully automatically sealed, stored, and then discarded.

• High-efficiency filtration, safe discharge: The air in the compounding area is filtered through HEPA H14 high-efficiency filters, reaching the ISO Class 5 standard. The high-efficiency full-exhaust ventilation system ensures that harmful gases such as toxic particulate gases, aerosols, and mists generated during drug compounding are safely discharged after being treated by high-efficiency filters.

• Dedicated disposable drug dissolver: The dedicated drug dissolver is specially designed to ensure pressure balance inside the vial during aspiration and injection, ensuring puncture precision, reducing liquid splashing, facilitating precise control of the amount of solvent injected into the vial, and at the same time reducing the residual amount of drug solution in the vial.

• Detection and feedback at key steps: All key steps of compounding have detection and feedback functions to ensure the compounding process is precise and error-free.

• Independent control procedures: To ensure the quality of drug compounding, IDolphin can set independent control procedures according to the characteristics of each drug and establish a database. After entering medical orders and prescriptions, and after the equipment identifies the drug and verifies the prescription, it can automatically execute parameters such as the amount of solvent injected, the amount of drug solution aspirated, and the intensity, method, and time of shaking for dissolution according to the drug, with stable operation and high consistency.

• Deep learning capability: It has deep learning capabilities for different compounding methods of various new drugs subsequently launched on the market. The equipment has strong adaptability to system updates and iterations, good compatibility, and strong expansion space.

• Full-process traceability: IDolphin can store data, pictures, and video materials from the entire process of drug compounding for traceability.

• Effectively ensuring dosage accuracy: Through a bionic-designed visual recognition system, it achieves more precise control of the residual amount of drug solution. For drug solutions that generate bubbles during compounding, the bionic-designed visual recognition system accurately identifies the boundary between the drug solution and bubbles through the difference in imaging caused by light penetrating between different media, thereby precisely identifying the drug solution aspiration precision and ensuring that the dosage accuracy of each compounded finished bag is controlled within ±3%.

• Seamless integration, intelligent verification: It can interface with the hospital HIS and PIVAS systems to identify prescriptions and perform intelligent verification.

• Multiple compounding modes: Supports single-prescription compounding mode, centralized drug arrangement compounding mode, and multi-prescription batch compounding mode. It has the function of combining drugs for non-whole-dose use of the same drug, and the function of recovering and reusing surplus drugs after non-whole-dose use.

3. Product Advantages

• Can meet the clinical compounding needs for large-dose prescriptions. The total number of drug vials loaded into the chamber in a single batch reaches 85, including 64 vials, 21 ampoules, 6 bags of base solution, and 12 drug dissolvers, all of which can be compounded in one batch. It has a secondary input function for drugs exceeding the number of workstations. The number of drugs loaded in a single batch is currently the highest in the world, and configuring the same number of drugs can reduce the number of loading times and increase compounding speed.

• Under different prescriptions, drugs, and compounding modes, the current clinical data is 10-21 seconds/vial.

• Fast compounding speed, capable of compounding about 36 bags per hour (calculated based on one bag of base solution containing 5 drugs).

• Supports various specifications of solvents used in domestic clinical practice, including 50ml-500ml solvent soft bags (including single-port and double-port), plastic bottles, stand-up bags, portable chemotherapy pumps, etc.

• Supports hazardous drugs packaged in more than 99% of currently clinically used ampoules and vials.

• Supports compounding of drugs in 1-50ml vials and drugs in 1-20ml ampoules.

• Can be used in different scenarios such as PIVAS, day chemotherapy, and general departments.

• Simple operation, cleaning, and maintenance.